Update to existing guidance to incorporate recent FDA PrEP medication approvals, and to clarify specific aspects of clinical care. These revisions were made to improve usability and increase implementation of the guideline based on comments received from clinicians providing PrEP care
Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the United States (2021 Update)
Clinician Guide